Allan Sturgess

2.1k total citations · 1 hit paper
42 papers, 1.6k citations indexed

About

Allan Sturgess is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Allan Sturgess has authored 42 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 15 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Allan Sturgess's work include Systemic Lupus Erythematosus Research (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Systemic Sclerosis and Related Diseases (7 papers). Allan Sturgess is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Systemic Sclerosis and Related Diseases (7 papers). Allan Sturgess collaborates with scholars based in Australia, United Kingdom and India. Allan Sturgess's co-authors include Ross L. Coppel, Lauren Grace Mackey, M. Eric Gershwin, Philip E. Morgan, Michael J. Davies, L McGuigan, T. Diamond, Richard J. Quinn, Ian Gotis‐Graham and M G Peterson and has published in prestigious journals such as Circulation, The Journal of Immunology and The American Journal of Medicine.

In The Last Decade

Allan Sturgess

41 papers receiving 1.6k citations

Hit Papers

Identification and specificity of a cDNA encoding the 70 ... 1987 2026 2000 2013 1987 100 200 300 400

Peers

Allan Sturgess
Comparison fields: 5 of 103
  • Rheumatology 540
  • Epidemiology 388
  • Hepatology 386
  • Immunology 384
  • Surgery 309
Replace Ana Tobar with:
Ana Tobar Israel
Giancarlo Labbadia Italy
Koji Kinoshita Japan
Elisa Menegatti Italy
Rocco Misiani Italy
Padmini Malladi United States
Noritoshi Kobayashi Japan
Zongwen Shuai China
Lie Dai China
Luis H. Silveira United States
Ana Tobar Israel View profile →
Citations per field, relative to Allan Sturgess
Allan Sturgess · 1×
Citations per year, relative to Allan Sturgess
Allan Sturgess · 1×

Countries citing papers authored by Allan Sturgess

Since Specialization
Citations

This map shows the geographic impact of Allan Sturgess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Sturgess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Sturgess more than expected).

Fields of papers citing papers by Allan Sturgess

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Sturgess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Sturgess. The network helps show where Allan Sturgess may publish in the future.

Co-authorship network of co-authors of Allan Sturgess

This figure shows the co-authorship network connecting the top 25 collaborators of Allan Sturgess. A scholar is included among the top collaborators of Allan Sturgess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan Sturgess. Allan Sturgess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 7
2 0
3
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
28
4 2
5
LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY
2
6
MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT
1
7
FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS
3
8 84
9 42
10 5
11 31
12 112
13 54
14 2
15 46
16 20
17 42
18 11
19 22
20 61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026